HA-GbL Citations (3)

Originally described in: Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.
Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM Curr Biol 2004 Jul 27;14(14):1296-302. PubMed Journal

Articles Citing HA-GbL

Showing 1 to 3 of 3 entries

Show entries

Search table:

Articles
SUMO modifies GbetaL and mediates mTOR signaling. Park SLL, Ramirez-Jarquin UN, Shahani N, Rivera O, Sharma M, Joshi PS, Hansalia A, Dagar S, McManus FP, Thibault P, Subramaniam S. J Biol Chem. 2024 Apr;300(4):105778. doi: 10.1016/j.jbc.2024.105778. Epub 2024 Feb 21. PubMed
Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein. Glidden EJ, Gray LG, Vemuru S, Li D, Harris TE, Mayo MW. J Biol Chem. 2012 Jan 2;287(1):581-8. doi: 10.1074/jbc.M111.304337. Epub 2011 Nov 14. PubMed
Regulation of mTORC1 complex assembly and signaling by GRp58/ERp57. Ramirez-Rangel I, Bracho-Valdes I, Vazquez-Macias A, Carretero-Ortega J, Reyes-Cruz G, Vazquez-Prado J. Mol Cell Biol. 2011 Apr;31(8):1657-71. doi: 10.1128/MCB.00824-10. Epub 2011 Feb 14. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.